No Picture
Trading Ideas

WTO must decide if U.S. complied with Boeing aid ruling, Airbus says

The World Trade Organization must decide whether the United States has fully complied with WTO rulings on illegal government aid to Boeing Co , and that process could take some time, a spokesman for Airbus said on Wednesday. The U.S. government on Wednesday told the WTO that it had fully complied with the WTO’s rulings since Washington State had now repealed its tax breaks for Boeing, and there was “no valid basis” for the European Union to retaliate against U.S. goods. …read more […]

No Picture
Business News

U.S. tells WTO ‘no valid basis’ for EU tariffs in Boeing-Airbus subsidy fight

The United States told the World Trade Organization on Wednesday it has fully complied with WTO findings that Washington state’s now-repealed tax breaks for Boeing were illegal and there was “no valid basis” for the European Union to retaliate against U.S. goods.

…read more […]

No Picture
Trading Ideas

The Silicon Valley Workplace Will Never Be the Same

(Bloomberg) — When the headquarters of Mission Bio reopens next week, employees will find many of the familiar perks they enjoyed before Silicon Valley went into lockdown have changed. Instead of the communal trays of catered lunches served a few times a week, each employee will get their own boxed meal. The snacks will remain free, but the soda machine and tub of almonds will be replaced with canned beverages, bottled water and individually wrapped protein bites. One new benefit: Every two weeks, the startup plans to provide Covid-19 tests onsite to any staff member who wants one.Mission Bio is …read more […]

Newsmakers

Manuscript Describes How CytoDyn’s (OTC: CYDY) Leronlimab Disrupts CCL5/RANTES-CCR5 Pathway, Thereby Restoring Immune Homeostasis, Reducing Plasma Viral Load, Reversing Hyper Immune Activation and Inflammation in Critical COVID-19 Patients

VANCOUVER, Washington, May 06, 2020 (GLOBE NEWSWIRE via COMTEX) — Manuscript Posted Online to Research Square and MedRxiv Pre-print Server CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO […]